SanBio Co. Ltd.
(OTC: SNBOY)
|
6:09 PM UTC, 04/09/24 | |||
---|---|---|---|---|
Last: $2.81 | Change: -2.67 | %Change: -48.72% | Volume: 211 |
Open: | $ 2.81 | Volume: | 211 | |
---|---|---|---|---|
High: | $ 2.81 | Yield(%) | 0.00 | |
Low: | $ 2.81 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 448.15M | |
EPS ($) | -0.23 | Shares Out: | 68.63M |
% Price Change (last 4 weeks): | 104.67 |
---|---|
% Price Change (last 13 weeks): | 131.77 |
% Price Change (last 26 weeks): | 32.01 |
% Price Change (last 52 weeks): | 53.12 |
% Price Change (year to date): | 31.15 |
Return on Equity (%): | -70.10 |
---|---|
Return on Assets (%): | -42.01 |
Return on Invested Capital (%): | -59.81 |
Gross Profit Margin (%): | n/a |
---|---|
Net Profit Margin (%): | n/a |
Operating Profit Margin (%): | 0.00 |
|
|
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $n/a |
52-wk low: | $n/a |
Bid: | $n/a |
Ask: | $n/a |
SanBio Co., Ltd. engages in the development, production and sale of regenerative cells medicines. It provides regenerative therapies for neurological disorders that include stroke, traumatic brain injury, eye diseases, and Parkinson's disease. The company was founded on February 27, 2013 and is headquartered in Tokyo, Japan.
|
SanBio Co. Ltd.
St. Luke Tower, 32/F 8-1 Akaishi-cho Chuo-Ku Tokyo TY 104-0044 Phone: 81.3.6264.3481 Fax: n/a http://www.sanbio.com |
Earnings (1year) ($): | -0.23 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 0.28 |
Cash Flow ($): | -0.27 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | n/a |
Price/Book (x): | 13.77 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 5.45 |
---|---|
Current Ratio (x): | 5.45 |
LT Debt/Equity (x): | 14.22 |
Total Debt/Equity (x): | 23.81 |